66 related articles for article (PubMed ID: 6682701)
1. Evaluation of single-agent cisplatin in the management of non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
Panettiere FJ; Vance RB; Stuckey WJ; Coltman CA; Costanzi JJ; Chen TT
Cancer Treat Rep; 1983 Apr; 67(4):399-400. PubMed ID: 6682701
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
Haas CD; Baker L; Thigpen T
Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.
Panettiere FJ; Leichman LP; Tilchen EJ; Chen TT
Cancer Treat Rep; 1984; 68(7-8):1023-4. PubMed ID: 6540144
[No Abstract] [Full Text] [Related]
4. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
Tamura A; Mikami A; Sagara Y; Hebisawa A
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung.
Casper ES; Gralla RJ
Cancer Treat Rep; 1979 Apr; 63(4):549-50. PubMed ID: 156068
[No Abstract] [Full Text] [Related]
6. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
8. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
[TBL] [Abstract][Full Text] [Related]
9. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
Lokich J; Auerbach M; Essig L; Fryer J; Fryer D
J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
[No Abstract] [Full Text] [Related]
11. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer].
Takanashi N; Hara N; Ichinose Y; Asoh H; Yano T; Yokoyama H; Miura T; Matsuoka Y; Tayama K; Ohta M
Gan To Kagaku Ryoho; 1993 May; 20(7):921-7. PubMed ID: 8387761
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced non-small cell lung cancer with bisantrene.
Fuks JZ; Van Echo DA; Garbino C; Kasdorf H; Aisner J
Cancer Treat Rep; 1983 Jun; 67(6):597-8. PubMed ID: 6305499
[No Abstract] [Full Text] [Related]
15. [Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer].
Xiao QM; Zhang WD; Zhou JH
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):397-8. PubMed ID: 12536753
[No Abstract] [Full Text] [Related]
16. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of VP-16-213 in non-small-cell lung cancer.
Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB
Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137
[TBL] [Abstract][Full Text] [Related]
19. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
Ohta M; Tsuchiya R; Shimoyama M; Sawamura K; Mori T; Miyazawa N; Suemasu K; Watanabe Y; Tomita M; Terashima M
J Thorac Cardiovasc Surg; 1993 Oct; 106(4):703-8. PubMed ID: 8412266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]